OBJECTIVE: To detect the maternal and fetal problems experienced by patients with non-cystic fibrosis (non-CF) bronchiectasis during pregnancy. MATERIAL AND METHODS: A total of 185 women aged over 18 years with medical records available, who were diagnosed as having non-CF bronchiectasis and followed in the outpatient clinic for bronchiectasis, were interviewed by phone between November 1, 2019 and December 31, 2019. Forty-seven women who accepted to participate, were able to understand and answer the survey, and had experienced at least 1 pregnancy, were included in the study, The survey questions were read and the answers were recorded. The same survey was administered to a control group of 95 women. RESULTS: It was found that the number of patients experiencing an increase in at least 1 of the symptoms of cough, sputum production, and dyspnea during pregnancy, and the number of visits to emergency departments for respiratory conditions, were statistically significantly higher (P < .001 and P < .001, respectively), and the rate of live births was significantly lower (P = .009) in the non-CF bronchiectasis group compared with the control group. No significant difference was found between the groups in the number of miscarriages, preterm births, cesarean section, extra visits to the obstetrics department, and the presence of anomalies in the infants. CONCLUSION: Among patients with non-CF bronchiectasis, it should be kept in mind that an increase may be seen in respiratory symptoms and the number of emergency department visits during pregnancy, and a decrease may be seen in the ratio of live births. These patients should be followed closely for these issues and measures should be taken accordingly.
OBJECTIVE: To detect the maternal and fetal problems experienced by patients with non-cystic fibrosis (non-CF) bronchiectasis during pregnancy. MATERIAL AND METHODS: A total of 185 women aged over 18 years with medical records available, who were diagnosed as having non-CF bronchiectasis and followed in the outpatient clinic for bronchiectasis, were interviewed by phone between November 1, 2019 and December 31, 2019. Forty-seven women who accepted to participate, were able to understand and answer the survey, and had experienced at least 1 pregnancy, were included in the study, The survey questions were read and the answers were recorded. The same survey was administered to a control group of 95 women. RESULTS: It was found that the number of patients experiencing an increase in at least 1 of the symptoms of cough, sputum production, and dyspnea during pregnancy, and the number of visits to emergency departments for respiratory conditions, were statistically significantly higher (P < .001 and P < .001, respectively), and the rate of live births was significantly lower (P = .009) in the non-CF bronchiectasis group compared with the control group. No significant difference was found between the groups in the number of miscarriages, preterm births, cesarean section, extra visits to the obstetrics department, and the presence of anomalies in the infants. CONCLUSION: Among patients with non-CF bronchiectasis, it should be kept in mind that an increase may be seen in respiratory symptoms and the number of emergency department visits during pregnancy, and a decrease may be seen in the ratio of live births. These patients should be followed closely for these issues and measures should be taken accordingly.
Authors: Edmund M T Lau; David J Barnes; Carmel Moriarty; Robert Ogle; Ruth Dentice; Jane Civitico; Aurora Avedello; Paul J Torzillo; Peter T Bye Journal: Aust N Z J Obstet Gynaecol Date: 2011-02-07 Impact factor: 2.100
Authors: Sonya L Heltshe; Emily M Godfrey; Tatiana Josephy; Moira L Aitken; Jennifer L Taylor-Cousar Journal: J Cyst Fibros Date: 2017-02-10 Impact factor: 5.482
Authors: F P Edenborough; G Borgo; C Knoop; L Lannefors; W E Mackenzie; S Madge; A M Morton; H C Oxley; D J Touw; M Benham; M Johannesson Journal: J Cyst Fibros Date: 2007-11-19 Impact factor: 5.482
Authors: Adam T Hill; Anita L Sullivan; James D Chalmers; Anthony De Soyza; Stuart J Elborn; Andres R Floto; Lizzie Grillo; Kevin Gruffydd-Jones; Alex Harvey; Charles S Haworth; Edwin Hiscocks; John R Hurst; Christopher Johnson; Peter W Kelleher; Pallavi Bedi; Karen Payne; Hashem Saleh; Nicholas J Screaton; Maeve Smith; Michael Tunney; Deborah Whitters; Robert Wilson; Michael R Loebinger Journal: Thorax Date: 2019-01 Impact factor: 9.139
Authors: Eva Polverino; Pieter C Goeminne; Melissa J McDonnell; Stefano Aliberti; Sara E Marshall; Michael R Loebinger; Marlene Murris; Rafael Cantón; Antoni Torres; Katerina Dimakou; Anthony De Soyza; Adam T Hill; Charles S Haworth; Montserrat Vendrell; Felix C Ringshausen; Dragan Subotic; Robert Wilson; Jordi Vilaró; Bjorn Stallberg; Tobias Welte; Gernot Rohde; Francesco Blasi; Stuart Elborn; Marta Almagro; Alan Timothy; Thomas Ruddy; Thomy Tonia; David Rigau; James D Chalmers Journal: Eur Respir J Date: 2017-09-09 Impact factor: 16.671